Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) /MEK/ERK pathway inhibitors, IDH mutation inhibitors, immune checkpoint inhibitors, and CAR-T
cell therapies
Timasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) , neurotransmitters, and β-
cell function, to develop a prognostic tool for MetS risk. Methods: We genotyped 40 genetic
Профилактика билиарных осложнений после обширных резекций печени: опыт одного центраМ. А. Нартайлаков,
M. A. Nartailakov,
Ф. Р. Нагаев,
F. R. Nagaev,
Д. М. Минигалин,
D. M. Minigalin,
М. Р. Бакеев,
M. R. Bakeev,
А. Г. Сафаргалина,
A. G. Safargalina (Креативная хирургия и онкология, №1, 2025) Prevention of biliary complications after extensive liver resections:
Single-center experience
determination of glial fibrillary acidic protein (GFAP) and anti-apoptotic B-
cell lymphoma-2 protein (Bcl-2
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) development, the degree of
cell differentiation, the occurrence of distant and regional metastases, as well
of DEGs was performed using Gene Ontology (GO) resources, and the
cell signaling pathway analysis of DEGs